Skip to main content

Table 3 Baseline characteristics

From: Nurse-led advance care planning with older people who have end-stage kidney disease: feasibility of a deferred entry randomised controlled trial incorporating an economic evaluation and mixed methods process evaluation (ACReDiT)

Description

Immediate entry (n = 17)

Deferred entry (n = 19)

All (n = 36)

Age (years)a

75.6 (6.81)

73.2 (5.01)

74.9 (6.89)

Age range (years)

67–92

65–83

 

Sex (male)

14 (82%)

16 (84%)

 

RRT b (years)c

1 (0.5–4.0)

3 (1.0–7.0)

2 (1.0–5.5)

Number of comorbiditiesc

2 (1.0–4.5)

3 (2.0–4.0)

2 (1.0–4.0)

Diabetes

7 (41%)

5 (26%)

 

Isaac’s Set Testa

31.7 (7.4)

30.6 (6.3)

31.1 (6.7)

CORE34a

0.48 (0.43)

0.75 (0.57)

0.62 (0.52)

KDQOL-36â„¢

 Symptomsa

77.1 (18.6)

67.9 (23.1)

72.2 (21.3)

 Effectsa

86.8 (12.1)

65.8 (25.6)

75.7 (22.7)

 Burdena

45.6 (27.5)

40.8 (30.2)

43.1 (28.7)

 SF12 physicala

37.3 (4.8)

30.7 (10.46)

33.8 (8.8)

 SF12 mentala

46.8 (10.7)

51.3 (12.4)

49.2 (11.7)

SHARED scorea

11.5 (6.9)e

8.3 (4.1)e

9.3 (5.2)

University degree

5 (29%)

1 (5%)

 

Household incomed

£10–20,000 (£10–60,000)

£10–20,000 (£10–70,000)

 

Renal Unit 1

13 (76%)

16 (84%)

 
  1. aMean (standard deviation)
  2. bRenal replacement therapy
  3. cMedian (inter-quartile range)
  4. dMedian, reported in increments of £10,000 (range)
  5. eData from 6 patients in immediate group and 13 in deferred group